| Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care M De Hert, CU Correll, J Bobes, M Cetkovich-Bakmas, DAN Cohen, I Asai, ... World psychiatry 10 (1), 52, 2011 | 2814 | 2011 |
| Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies M Solmi, J Radua, M Olivola, E Croce, L Soardo, G Salazar de Pablo, ... Molecular psychiatry 27 (1), 281-295, 2022 | 2319 | 2022 |
| How mental health care should change as a consequence of the COVID-19 pandemic C Moreno, T Wykes, S Galderisi, M Nordentoft, N Crossley, N Jones, ... The lancet psychiatry 7 (9), 813-824, 2020 | 1850 | 2020 |
| Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large‐scale meta‐analysis of 3,211,768 patients … CU Correll, M Solmi, N Veronese, B Bortolato, S Rosson, P Santonastaso, ... World Psychiatry 16 (2), 163-180, 2017 | 1628 | 2017 |
| The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness J Firth, N Siddiqi, AI Koyanagi, D Siskind, S Rosenbaum, C Galletly, ... The Lancet Psychiatry 6 (8), 675-712, 2019 | 1284 | 2019 |
| Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review … D Vancampfort, B Stubbs, AJ Mitchell, M De Hert, M Wampers, PB Ward, ... World psychiatry 14 (3), 339-347, 2015 | 1273 | 2015 |
| Metabolic and cardiovascular adverse effects associated with antipsychotic drugs M De Hert, J Detraux, R Van Winkel, W Yu, CU Correll Nature Reviews Endocrinology 8 (2), 114-126, 2012 | 1266 | 2012 |
| Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents CU Correll, P Manu, V Olshanskiy, B Napolitano, JM Kane, AK Malhotra Jama 302 (16), 1765-1773, 2009 | 1239 | 2009 |
| Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level M De Hert, DAN Cohen, J Bobes, M Cetkovich-Bakmas, S Leucht, ... World psychiatry 10 (2), 138, 2011 | 1057 | 2011 |
| Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ... American Journal of Psychiatry 174 (3), 216-229, 2017 | 1026 | 2017 |
| Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies CU Correll, S Leucht, JM Kane American Journal of psychiatry 161 (3), 414-425, 2004 | 924 | 2004 |
| Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder CU Correll, J Detraux, J De Lepeleire, M De Hert World psychiatry 14 (2), 119-136, 2015 | 904 | 2015 |
| Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program JM Kane, DG Robinson, NR Schooler, KT Mueser, DL Penn, ... American Journal of Psychiatry 173 (4), 362-372, 2016 | 902 | 2016 |
| Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression CU Correll, B Galling, A Pawar, A Krivko, C Bonetto, M Ruggeri, TJ Craig, ... JAMA psychiatry 75 (6), 555-565, 2018 | 805 | 2018 |
| Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment CU Correll, NR Schooler Neuropsychiatric disease and treatment, 519-534, 2020 | 759 | 2020 |
| Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials S Leucht, TRE Barnes, W Kissling, RR Engel, C Correll, JM Kane American Journal of Psychiatry 160 (7), 1209-1222, 2003 | 727 | 2003 |
| Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis D Vancampfort, CU Correll, B Galling, M Probst, M De Hert, PB Ward, ... World Psychiatry 15 (2), 166-174, 2016 | 725 | 2016 |
| EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA … B Stubbs, D Vancampfort, M Hallgren, J Firth, N Veronese, M Solmi, ... European Psychiatry 54, 124-144, 2018 | 643 | 2018 |
| National trends in the mental health care of children, adolescents, and adults by office-based physicians M Olfson, C Blanco, S Wang, G Laje, CU Correll JAMA psychiatry 71 (1), 81-90, 2014 | 588 | 2014 |
| Non‐adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies JM Kane, T Kishimoto, CU Correll World psychiatry 12 (3), 216-226, 2013 | 579 | 2013 |
